19-10987775-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6BP7
The NM_001387283.1(SMARCA4):c.969G>T(p.Ser323Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S323S) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001387283.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | MANE Plus Clinical | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 36 | NP_001374212.1 | ||
| SMARCA4 | NM_003072.5 | MANE Select | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 35 | NP_003063.2 | ||
| SMARCA4 | NM_001128849.3 | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 36 | NP_001122321.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | MANE Plus Clinical | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 36 | ENSP00000495368.1 | ||
| SMARCA4 | ENST00000344626.10 | TSL:1 MANE Select | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 35 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.969G>T | p.Ser323Ser | synonymous | Exon 6 of 35 | ENSP00000493975.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000479 AC: 1AN: 208894 AF XY: 0.00000868 show subpopulations
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
The c.969G>T variant (also known as p.S323S), located in coding exon 5 of the SMARCA4 gene, results from a G to T substitution at nucleotide position 969. This nucleotide substitution does not change the serine at codon 323. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Rhabdoid tumor predisposition syndrome 2 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at